These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15510590)
21. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island. Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM Breast J; 2011; 17(1):24-31. PubMed ID: 21129090 [TBL] [Abstract][Full Text] [Related]
22. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years. Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204 [TBL] [Abstract][Full Text] [Related]
23. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies. Lester J Clin J Oncol Nurs; 2007 Oct; 11(5):619-22. PubMed ID: 17962169 [TBL] [Abstract][Full Text] [Related]
24. Breast cancer decline mirrors fall in hormone use, spurs both debate and research. McNeil C J Natl Cancer Inst; 2007 Feb; 99(4):266-7. PubMed ID: 17312300 [No Abstract] [Full Text] [Related]
25. The "epidemic" of breast cancer in the U.S.--determining the factors. King SE; Schottenfeld D Oncology (Williston Park); 1996 Apr; 10(4):453-62; discussion 462, 464, 470-2. PubMed ID: 8723277 [TBL] [Abstract][Full Text] [Related]
26. Risk factors for breast cancer in elderly women. Sweeney C; Blair CK; Anderson KE; Lazovich D; Folsom AR Am J Epidemiol; 2004 Nov; 160(9):868-75. PubMed ID: 15496539 [TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and breast disease. McGonigle KF; Huggins GR Fertil Steril; 1991 Nov; 56(5):799-819. PubMed ID: 1936311 [TBL] [Abstract][Full Text] [Related]
28. Primary prevention of breast cancer: new approaches. Cummings SR Maturitas; 2007 May; 57(1):39-41. PubMed ID: 17391879 [TBL] [Abstract][Full Text] [Related]
29. Tamoxifen prophylaxis in breast cancer. Love RR Oncology (Williston Park); 1992 Jul; 6(7):33-8; discussion 38-40, 43. PubMed ID: 1386239 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive breast cancer screening. Programs now include individual risk assessment. Cardenas K; Frisch K Postgrad Med; 2003 Feb; 113(2):34-6, 39-40, 43-6. PubMed ID: 12611113 [TBL] [Abstract][Full Text] [Related]
31. UICC Multidisciplinary Project on Breast Cancer: the epidemiology, aetiology and prevention of breast cancer. Miller AB; Bulbrook RD Int J Cancer; 1986 Feb; 37(2):173-7. PubMed ID: 3455923 [TBL] [Abstract][Full Text] [Related]
32. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Powles T; Eeles R; Ashley S; Easton D; Chang J; Dowsett M; Tidy A; Viggers J; Davey J Lancet; 1998 Jul; 352(9122):98-101. PubMed ID: 9672274 [TBL] [Abstract][Full Text] [Related]
33. Prevention and screening for breast cancer. Harper GR; Englisbe BH Cancer Detect Prev; 1993; 17(4-5):551-5. PubMed ID: 8242657 [TBL] [Abstract][Full Text] [Related]
34. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019 [TBL] [Abstract][Full Text] [Related]
35. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. Grabrick DM; Hartmann LC; Cerhan JR; Vierkant RA; Therneau TM; Vachon CM; Olson JE; Couch FJ; Anderson KE; Pankratz VS; Sellers TA JAMA; 2000 Oct; 284(14):1791-8. PubMed ID: 11025831 [TBL] [Abstract][Full Text] [Related]
36. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606 [TBL] [Abstract][Full Text] [Related]
37. Cyclical mastalgia and breast cancer risk: results of a French cohort study. Plu-Bureau G; Lê MG; Sitruk-Ware R; Thalabard JC Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1229-31. PubMed ID: 16775187 [TBL] [Abstract][Full Text] [Related]
38. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663 [TBL] [Abstract][Full Text] [Related]
39. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172 [TBL] [Abstract][Full Text] [Related]
40. More controversy over breast cancer rates in the USA. Brown S Menopause Int; 2007 Jun; 13(2):51-2. PubMed ID: 17802647 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]